Español    I    English            

Official body of scientific
expression of


Chilean Society of
Periodontology



Chilean Society of Oral
Oral Implantology



Chilean Society of Prosthetics and
Oral Rehabilitation

 


Chilean Society of
Odontopediatrics

 


Ibero-Panamerican Federation
of Periodontics

 


Ibero-Latin-American Association
of Oral Rehabilitation(AILARO)

Indexed in:

Scielo, ScienceDirect,
Latindex, Redalyc

Founded in 2008, the scientific Journal of Periodontics, Implantology and Oral Rehabilitation (PIRO) is the official body of scientific expression of the Chilean Society of Periodontology (www.spch.cl), the Chilean Society of Prosthetics and Oral Rehabilitation (www.rehabilitacionoral.cl) and the Chilean Society of Oral Implantology (www.sioch.cl). Beisdes, since 2011 it is the official body of scientific expression of the  Ibero-Panamerican Federation of Periodontics (www.fippdentalearning.org) and since May 2012 of the Ibero-Latin-American Association of Oral Rehabilitation (AILARO).

Indexed in: Scielo, ScienceDirect, Latindex, Redalyc

Publication rules

 

  1. GENERAL: The scientific Journal of Periodontics, Implantology and Oral Rehabilitation (www.revistapiro.cl) is the body of scientific expression of the Chilean Society of Periodontology, the Chilean Society of Prosthetics and Oral Rehabilitation and the Chilean Society of Oral Implantology. It publishes 3 issues per year.


  2. ETHICAL RESPONSIBILITIES: The scientific journal PIRO adheres to the ethical standards for the research and publication described next:igación y publicación descritas a continuación:

      2.1Authorship and acknowledgements: all the authors of a manuscript must agree with its presentation in the journal. The scientific journal PIRO adheres to the definition of “author” created by the International Committee of Medical Journal Editors (ICMJE). According to the ICMJE, the criteria of authorship should be based on 1) substantial contributions to the conception and design, data acquisition or analysis and data interpretation, 2) critical revision of the draft of the article and its significant intellectual content and 3) approval of the version to be published. The authors should meet all the conditions.
      All the authors and coauthors should be listed in the presentation of the manuscript (including their email). Those who do not qualify as authors should be listed in the acknowledgements.
      The contributors who are not recognized as authors should be listed in the “acknowledgment” section.

      2.2Ethical approval: when experiments involving humans are described, the authors should indicate in the “methods” section if the procedures followed are in accordance with the ethical standards of the human research ethics committee in charge, with the World Medical Association and the Declaration of Helsinki (version 2008) available at: http://www.wma.net/es/30publications/10policies/b3 and with the local additional requirements of the place where the research was carried out. The manuscripts should enclose the informed consent of every person involved in the study and the approval certificate of the       corresponding ethics committee.
      When using animals in experiments, the authors should indicate if they followed the standards of an international research institution or council or a national law regulating the care and use of laboratory animals.
      The Editor and/or the reviewers reserve the right to reject the manuscripts if there is doubt about whether the appropriate methods were used.

      2.3Trials: clinical trials should be informed using the CONSORT standards available at www.consort-statement.org. The CONSORT checklist must also be included in the presentation material.

      2.4DNA sequences and crystal structure determination: no works will be accepted without a Genbank or Brookhaven number, respectively, in works including information about DNA sequences and crystal structure determination.

      2.5Conflict of interest and funding source: the authors should declare the origin of any financial support received. There is a conflict of interest when the author (and/or coauthors) had financial or personal relationships that may have biased or influenced inappropriately their actions. In this case, they should indicate when there is a relationship (direct or indirect) with the work described by the authors in their manuscript. Potential sources of conflict of interest can be: ownership of patent or stock, being a Board member of a company related to the research, being a member of an Advisory Board or Consulting Committee of a company and receiving fees from any company involved in the study.  The existence of a conflict of interest does not prevent the publication of the article in the Journal.
      It is the responsibility of the corresponding author that all the authors fill the conflict of interest form and enclose it when presenting the manuscript. The conflict of interest statement should be included in the “acknowledgment” section.

      2.6Appeal a decision: in exceptional circumstances, the authors can appeal the editorial decision. For this, they should write an email to the editorial office, explaining in detail the reason of the appeal against the editorial decision.
      It is important to consider that all the reviews and re-sending of articles should include a response letter and the changes in the manuscript should be highlighted in order to help the reviewers..

      2.7Permissions: the authors are responsible for obtaining the permissions to reproduce partially the material of other publications (text, tables or figures). These permissions should be requested to the author, the Editorial that published the mentioned material and the institution that funded the project. They should be enclosed in the presentation of the manuscript. Additionally, the authors should include a statement saying that the content of the article is original, that it has not been published before and has been neither sent nor submitted for publication to any other journal, either totally or partially. Not to reveal this information is a serious failure to the science ethics..

  3. PRESENTATION OF THE MANUSCRIPT: the manuscripts should be sent electronically through the online site http://www.revistapiro.cl. The use of an online site for the sending and peer reviews allows an immediate distribution of the manuscripts and accelerates the review process. It also allows the authors to follow the state of their manuscripts. The complete instructions for the presentation of the document are available in the website..
    It is important to consider that all the reviews and re-sending of articles should include a response letter and the changes must be highlighted in the manuscript in order to help the reviewers.

      3.1Manuscript files: the manuscripts should be uploaded as Word files (.doc) not write-protected. The text file should content the entire manuscript, including the title page, the abstract (Spanish and English), keywords (Spanish and English), clinical references, main text, references, acknowledgment, statement of funding source and any possible conflict of interest, tables and legends of figures, but no embedded figures. In the text, any figure must be referred to as “figure 2”, “Figure 2” and the individual files should be uploaded with the same name. The files with figures should be uploaded separately from the main text. Although the GIF, JPEG, PICT or bits map are acceptable for the presentation, only high-resolution TIF or EPS files are advisable for the printing.
      The manuscripts should be formatted as described in the following guideline. Make sure that all the elements (figures and tables) are quoted in the main text

      3.2Anonymous review: all the manuscripts submitted to the Scientific Journal PIRO will be reviewed by two or more peers of the area. The documents inconsistent with the general objectives of the journal will be returned immediately without being reviewed. The Scientific Journal PIRO only uses blind review. The names of the reviewers will not be revealed to the authors.

      3.3Suggest a reviewer: The Scientific Journal PIRO tries to make the review process as fast as possible in order to allow a quick publication of new scientific data. In order to facilitate this process, the author can suggest the name and email of a potential international reviewer. A part from this option, the editor will select one or two additional reviewers.

      3.4Suspension of the presentation during the submission process: you can suspend a presentation at any stage before pressing the “send” button and save it for later. You will find your manuscript in “unsubmitted manuscript” and you can click the “continue presentation” button when you decide to continue.

      3.5Sent confirmation email: after the presentation, you will receive an email to confirm the receipt of the manuscript. If you don’t receive the confirmation within 24 hours, check your email address in the system. If the email address is correct, please write to revistaclinicapiro@gmail.com revistaclinicapiro@gmail.com  

      3.6Re-sending a manuscript: if the manuscript was rejected, you can send a modified version of the manuscript. This should be presented as a new manuscript, following the guidelines previously described under the point 3.2. Besides, you should upload the comments about the previous review as “complementary files to review”.


  4. TYPES OF MANUSCRIPTS ACCEPTED:the Scientific Journal PIRO publishes original research articles, systematic reviews and clinical reports; the bibliographical reviews are requested by the Editor. Any manuscript submitted to review is expected to be unpublished material.

    Original research articles/systematic reviews: the articles sent to this section will be about Periodontics, Prosthetics, Implantology, Oral Surgery, Pediatric Dentistry, Implantology and Preprosthetics, Oncology and Reconstructive Surgery, Orthognatic Surgery, Esthetics and Craniofacial Anomalies, Craniomaxillofacial Trauma, Temporomandibular Joint, salivary glands, among others. They can be research articles and experimental surgery or clinical trials

    Clinical cases/clinical reports can consist of the description of one or more clinical cases of special interest, as well as new surgical techniques or variations of them, analysis of the results obtained with a particular technique or with a treatment of a particular disease.

    Letter to the Editor: objections or comments related to previously published works or observations or briefly written experiences will be published. The letters about articles previously published in the journal will provide a right of reply to the authors, who will be able to respond with a letter of similar length within one month. The convenience of the publication of the response will be valued by the Editorial Board.

    The Bibliographical Review is requested exclusively by the Journal Editor, about a particular topic and of interest to the Journal.



  5. STRUCTURE AND FORMAT OF THE MANUSCRIPT

      5.1Format:
      Language: the language of publication is Spanish; articles in English and Portuguese are received too.
      Abbreviations, symbols and nomenclature: only the abbreviations common in the medical and dental field should be used and they should be avoided in the title and the abstract. The first time that an abbreviation is mentioned, it should be preceded by the entire term to which it refers, except for common units of measurement that will be expressed according to the International System of Unit. The chemical, physical, biological and clinical units will always have to be strictly defined.
      All the manuscripts should be written with Arial font, size 12, double-spaced, A4 size and all the pages should be numbered. In the case of original articles and systematic reviews, the maximal length will be 10 pages (abstract and bibliography not included); clinical cases, 6 pages ; letter to the director, 2 pages. For the other sections, please write to revistaclinicapiro@gmail.com  

      5.2Structure: All the articles sent to the Scientific Journal PIRO should include

      • Title page
      • Conflict of interest and funding source
      • Clinical relevance
      • Abstract and key words in Spanish
      • Abstract and key words in English
      • Introduction
      • Material and methods
      • Results
      • Discussion
      • References
      • Tables (if applicable)
      • Legends of figures (if applicable)
      • Figures (when applicable and uploaded as separate files)


      Title page: it should be brief and contain no more than 100 characters, including the spaces. The title page should include the main title with no more than 40 words; given name and first last name of the authors (or both last names hyphenated); complete names of the institutions of each author (not including academic or professional position) and the name, address, phone number and email of the corresponding author. This page should be presented in a file separate from the rest of the manuscript.

      Conflict of interest and funding source: the authors must reveal all the sources of financial institutional support, private and corporative for their research. Material providers (for free or with discount) should be mentioned as source of funding and their location included (city, country and state). The authors must also reveal any potential conflict of interest, such as patents, properties, participation, consulting, fees, supply of materials by the manufacturer. The conflicts of interest and funding sources for the research will be published in a section called “Declaration of conflict of interest and funding source”.
      Abstract: it will be limited to 200 words and should not contain any abbreviation or reference. The abstract should be organized according to the contents of the paper.
      For original research articles, the abstract should be organized with “aim, material and methods, results and conclusions”.
      For clinical trials, it is recommended to include in the final abstract the record number of the clinical trial in some public database, like clinicaltrials.gov.
      The abstract should be presented in Spanish and English; in case of an article written in Portuguese or English, an abstract in Spanish should be included.
      At the end of the abstract, 6 keywords maximum should be included according to the list from Medical Subject Headings (MeSH) of the Index Medicus/Medline available at http://www.nlm.nih.gov/mesh/MBrowser.html. The keywords should be in Spanish and English.


      Clinical relevance: it should not exceed 100 words and should not be a repetition of the abstract. It should provide a clear and brief explanation of the basis of the study, of what was known before and of how the results advance in knowledge in this field. If necessary, suggestions about the clinical practice can be included too.
      They should be structured with the following headlines: scientific justification for the study, principal results and practical consequences.

      Acknowledgments
      : they will only be expressed to: the persons or entities who contributed significantly to make the work possible and whose inclusion as authors cannot be justified; the acknowledgment for technical help should be expressed in a separate paragraph, different from the other acknowledgments.
      All the persons mentioned in the Acknowledgments should know and approve their inclusion in the mentioned section.

      5.3Original research articles: the articles submitted to this section should deal with Periodontics, Prosthetics, Implantology, Oral Surgery, Pediatric Dentistry, Implantology and Preprosthetics, Oncology and Reconstructive Surgery, Orthognatic Surgery, Esthetics and Craniofacial Anomalies, Craniomaxillofacial Trauma, Temporomandibular Joint, salivary glands, among others. The maximal amount of words is 3500, with 7 elements maximum (figures and tables).
      The main text of the original articles should be organized as follows: Introduction, material and methods, results and discussion, bibliographical references (maximum 25, see section 5.7).
      Introduction: the objectives of the work must be clearly mentioned and the basis must be summarized, without an extent review of the theme and removing historical memories. Only the references that are strictly necessary will be mentioned.
      Material and methods: in this section, the place, time and population of the study must be specified. It must include enough information about the design; it must describe the selection of the individuals studied with detailed methods, equipment and procedures with enough details to make it possible for other researchers to reproduce the study. The type of statistical analysis used must be indicated, specifying the confidence interval. The studies will come with the corresponding experiments and control groups; if not, the measures adopted to avoid bias will be explained, and their possible effect on the conclusions of the study will be commented. If the methodology is original, the reason leading to its use will be explained together with its possible limitations. With special mention, the clinical monitoring of the patients or animals must be long enough to allow the assessment of the procedure practiced. Neither names nor initials of the patients should be used. The generic name of the drug(s) used (avoiding the commercial name) will be informed, together with the dose and the route of administration. The ethical standards followed by the researchers in human as well as in animal studies will be briefly described. The studies with humans must be expressly approved by the local ethics and clinical trials committee and this must appear in the manuscript.

      • Clinical trials: they should be informed using the CONSORT standards.
      • Statistical analysis: enough details should be provided as for the statistical analysis carried out.
      • Human experimentation: the experimentation on humans will only be published if the research was carried out according to the ethical principles, including the World Medical Association and the Declaration of Helsinki (version 2008) and the additional requirements of the place where the research was made. Additionally, a statement declaring that all the experiments were carried out with the understanding and consent of each individual should be enclosed. Also, a statement confirming that the study was reviewed and approved by an Ethics Committee should be included.

        When using animals in experiments, the authors should clearly indicate if the appropriate measures were taken to minimize the pain or discomfort. The experiments should be performed following the guidelines provided by the National Institute of Health (NIH) in the USA, with respect to the care and use of animals in experiments, or with the Directive of the Council of the European Communities of 24 November 1986 (86/609/CEE) and according to the local laws and regulations.

        All the studies with humans and animals should include an explicit statement in this section, identifying the approval of the Ethics Committee for each study. The editor and the reviewers reserve the right to reject the manuscripts, in case of doubts about the use of appropriate procedures.

        Results: the results must be clear and concise and must include the required minimum tables and figures. They will be presented, so as not to duplicate and repeat data in the text and the figures and tables.

        Discussion: the following standard can be followed: 1) conclusion based exclusively on what the results show. Any kind of conclusion that cannot be clearly deduced from the results obtained should be avoided; 2) importance, relevance of the research completed; 3) strengths and 4) limits of the findings; and 5) future vision in light of the results.

      5.4Clinical cases/ clinical reports: they could consist in the description of one or more clinical cases of special interest as well as new surgical techniques or variations of them, analysis of the results obtained with a particular technique or in the treatment of a particular disease. The maximum length is 6 A4 pages. The abstract and its translation will have a maximal length of 150 words. The maximum number of signing authors is 6. Four keywords in Spanish and English will be attached. The number of bibliographical references should not exceed 15. (see section 5.7). A maximum of 7 items (figures and/or tables) will be accepted.

      The main text of the clinical reports should be structured with:
      • Introducción
      • Informe del caso
      • Discusión y conclusión
      • Referencias (ver sección 5.7-Vancouver)

      5.5Letters to the Editor: objections or comments related to previously published works or observations or briefly written experiences will be published. The maximal length should not exceed 2 A4 pages and a maximum of 10 bibliographical references will be accepted. The number of signing authors is limited to 4. The letters about articles previously published in the journal will provide a right of reply to the authors, who will be able to respond with a letter of similar length within one month. The convenience of the publication of the response will be valued by the Editorial Board. The abstract and its translation will have 250 words. Four keywords in Spanish and English will be attached and the bibliography cannot exceed 50 references.

      5.6Bibliographical reviews: they are requested by the Editor to experts in the field, to comment about topics of general interest and of scientific accuracy. They should have a maximal length of 4000 words, without pictures or tables. The maximum quantity of quotes permitted is 100.

      The main manuscript of the reviews should be organized as follows:
      • Introducción
      • Revisión de la literatura actual
      • Discusión y conclusión
      • Referencias (ver sección 5.7-Vancouver)

      5.7Bibliography (Vancouver): only the references considered important and read by the authors will be included, and in a number not superior to the maximum corresponding to each section. The bibliography will be presented according to the order of appearance in the text and with the corresponding correlative numbering. In the article, the numbering of the quote will always be superscripted, according to the “Uniformity requirements for manuscripts presented for publication in biomedical journals” elaborated by the International Committee of Medical Journal Editors, available at http://www.icmje.org/. The name of the journals must be abbreviated according to the style used in the Index Medicus/Medline (See List of Journals Indexed”, included every year in the January issue of the Index Medicus/Medline (http:// www.nlm.nih.gov/mesh/MBrowser.html). The inclusion of text books and minutes of meetings as bibliographical references should be avoided. Sentences like “non-published observations” or “personal communication” cannot be used as bibliographical quotes. Quotes at the footnote are not accepted.   
      Below, a few examples of the formats of bibliographical quotes:

      Journal

      1. Original article. All the authors must be included if there are 6 or less. Otherwise, name the 6 firsts followed by “et al”::
        Tarnow DP, Elian N, Fletcher P, Froum S, Magner A, Cho SC, et al. Vertical distance from the crest of bone to the height of the interproximal papilla between adjacent implants. J Periodontol. 2003;74:1785-8.
        Tarnow DP, Cho SC, Wallace SS. The effect of inter-implant distance on the heigth of inter-implant bone cresta. J Perio¬dontol. 2000;71:546-9.
      2. Corporate author:
        Symptomatic multifocal osteonecrosis. A multicenter study. Collaborative Osteonecrosis Group. Clin Orthop Relat Res. 1999;(369):312-26.
      3. Supplement to an edition of the journal:
        Takagi M. Neutral proteinases and their inhibitors in the loo¬sening of total hip prostheses. Acta Orthop Scand. 1996;67 Suppl 219: 29-33.
      4. Supplement to an edition of an issue:
        Glauser TA. Integrating clinical trial data into clinical practi¬ce. Neurology. 2002;58 12 Suppl 7:S6-12.
      5. Issue without edition:
        Jané E. Sistemas de salud y desarrollo. Quadern CAPS. 1999;(28):7–16. Libros y otras monografías.

        Libros y otras monografías
      6. Personal author(s):
        Pauwels F. Atlas zur Biomechanik der gesunden und kranken Hüfte. Wurzburg: Springer Verlag; 1973.
      7. Director(s)/compiler(s) of edition as author(s)::
        Pérez de los Cobos J, Valderrama JC, Cervera G, Rubio G, editores. Tratado SET de trastornos adictivos. Madrid: Ed. Panamericana; 2006.
      8. Book chapter:
        Llanos-Cubas LF, Martín-Santos C. Anatomía funcional y bio¬mecánica del raquis lumbar. En: Cáceres E, Sanmartí R, edi¬tor. Lumbalgia y lumbociatalgia. Tomo I. Barcelona: Masson SA; 1998. p. 1–21
      9. Published presentation:
        Sanz-Aguado MA. La epidemiología y la estadística. En: Sánchez-Cantalejo E, editor. Libro de Ponencias del V Encuentro Marcelino Pascua; 16 junio 1995; Granada, España. Granada: Escuela Andaluza de Salud Pública; 1996. p. 35–44.
      10. Doctoral thesis:
        García-Rueda FJ. Alteraciones del osteoclasto en la enfer¬medad de Paget [tesis doctoral], Salamanca, Universidad de Salamanca, 1987.
      11. Scientific or technical report:
        Dirección General para las Drogodependencias y Adicciones. Catálogo de los servicios asistenciales de los centros de tra¬tamiento ambulatorio de Andalucía. Sevilla: Junta de Anda¬lucía; 2003.

        Other published works
      12. Communication to a congress:
        Álvarez-Villas P, Cebamanos J, Escuder MC, Ribau MA, Balles¬ter J. Osteonecrosis meseta tibial. Diagnóstico, diagnóstico diferencial y tratamiento. Actas del 33.o Congreso Nacional SECOT; Octubre 1996. Alicante. SECOT; p. 202.
      13. Newspaper article:
        Sampedro J, Salvador I. Cientos de comercios de Castilla-La Mancha venden ilegalmente fármacos para el ganado. El País. 19 octubre 1999; p. 37 (col. 1-4).
      14. Legal Material:
        Ley de Prevención de Riesgos Laborales. L. N.º 31/1995 (8 noviembre 1995).
      15. Digital archive:
        EPISAME Versión Macintosh [CD-ROM]. Madrid: Escuela Nacional de Sanidad, Universidad Nacional de Educación a Distancia; 1998.
      16. Web Page:
        Buscador de revistas médicas en Internet. Granada: Depar¬tamento de Histología, Universidad de Granada [actualizado 30 octubre 1998; citado 3 noviembre 1998]. Disponible en: http://histolii.ugr.es/journals.html
      17. Document on the internett
        Plan Nacional sobre Drogas. Encuesta domiciliaria 2005-2006. [consultado 06/06/2007]. Disponible en: http://www.pnsd. msc.es/Categoria2/observa/pdf/Domiciliaria2005-2006.pdf
      18. Article of a Journal in digital format:
        Berger A, Smith R. New technologies in medicine and medical journals. BMJ [edición electrónica]. 1999 [citado 14 enero 2000]; 319: [aprox. 1 pág.]. Disponible en: http://www.bmj. com/cgi/content/full/319/7220/0.
      19. Monograph in digital format:
        Badía X, Lizán L. Estudios de calidad de vida. En: Martín Zurro A, Cano Pérez JF, editores. Atención primaria. 5th ed (monografía en Internet): España: Elsevier; 2006 (citado 29 mayo 2006). Disponible en: http://www.elsevier.es/librosvi-vos/martinzurro/indices.asp 17.
      20. Audiovisual material:
        VIH+/SIDA: elementos de prevención [videocasete]. Cornellà de Llobregat: Aula de Formación; 1998.
      21. Non-published material
        In press (in this case, the authors must get the confirmation of the future publication of the quoted work): Sardi NA, Rapp E, Vakka LAO. Fish consumption and the risk of Alzheimer’s disease. Eur J Nutr Neurol Sci. En prensa 2004.

      5.8Tables, figures and legends of figures:

      • Tables: the unit of measurement should be included in the title of the column. They will be marked in the text in a correlative way with Arabic numbers (for example table 1). They should be double-spaced, without vertical resolutions, in separate pages and will include: (a) numbering of the table with Arabic numbers; (b) corresponding headline-title; (c) the abbreviations used in alphabetical order in the lower part of each table. They should be clear and without corrections; the initials and abbreviations will always be accompanied with an explanation in the footnote. If a table is longer than one sheet, the headline should be repeated in the next page. The journal will accept tables of a maximum size of one printed page. They should complete and not double the text.

      • Figures: they can be photos or graphs and should be planned for the width of 1 column (8,0 cm), 1,5 column width (13,0 cm) or 2 width of columns (17,0 cm) and should be appropriate for the photocopy reproduction of the printed version of the manuscript. They will be uploaded independently of the text. They will be numbered correlatively with Arabic numbers (example fig. 1). If a figure is formed by more than one picture, they will be identified in the text with the number and a lower case letter (example fig. 1a, fig. 1b). The letters in the figures should be lower-case with the first letter upper case. The units should have one only space between the number and the unit and follow the SI nomenclature or the nomenclature common to a particular field. Thousands should be separated by a period (1 000). The unusual units or abbreviations should be spelled completely or defined in the legend.
        The figures should be in bmp, jpg or tiff format, minimum 300 points per inch and minimum size of 8 cm. The Word and Powerpoint graphs are not recommended for printed images.
        In the case of scanned images, the resolution to guarantee a good reproduction should be: lineart: >600dpi; tones (including gel photographs) > 300 dpiM; figures containing half tone and line images >600 dpi.
        Permissions: if all or part of published illustrations are used, you should get the Copyright permission from the owner and the editorial that published the material. It is the responsibility of the author to obtain them in writing and provide the editors with copies.
        If photos or data from the patients are reproduced, they should not identify the individual. In all cases, the authors should have obtained the informed consent/assent from the patient authorizing its publication, reproduction and disclosure on paper and on the internet in the Scientific Journal PIRO. The identification of the patients should be avoided. If not possible, you should have the informed consent/assent in writing.

      • Legends of figures: it should be a separate section of the manuscript and should start with a brief title for the complete figure and continue with a brief description of each image and of the symbols used; they should not contain any instruction on the methods. The Font style should be Helvetica or Sans Serif, size 10. In the In histological reproductions, the staining used and the increase should be specified.

      5.9Additional material: the data, figures or tables not published in the printed version are considered additional material. They will appear in the online version and should be uploaded as “Support information for the review and publication online only”..

     

  6. AFTER THE APPROVAL: when a paper is approved for publication, he manuscript will be sent to the journal production.

      6.1Corrections test: the author will receive an email containing a link to a website. The test can be downloaded from this site (you will need Acrobat Reader, downloadable from www.adobe.com/products/acrobat/readstep2.html). The test must be returned to the editor in no more than 3 days after receiving it. Only corrections of typography are allowed; pictures, tables and/or graphs can only be modified in the case of being blurred..

      6.2Publishing before printing: The complete text of the articles is published online previous to their publication in the printed edition. These articles have already been reviewed and approved by the author; therefore, modifications are not allowed. Because of the nature of the publication, it does not include the edition, page number and therefore cannot be quoted in the traditional way. To be quoted, you can do so through the DOI (Digital Object Identifier) assigned (for further information you can check http://www.doi.org/faq.html)

    The judgments and opinions expressed in the articles and communications published in the Journal of Periodontics, Implantology and Oral Rehabilitation are the sole responsibility or thinking of the author or authors and do not necessarily reflect the opinion of the Editorial Board. Both the Editorial Board and the publishing company decline any liability for this material. Neither the Editorial Board nor the publishing company guarantee or support any of the products advertised in the Journal, and they do not guarantee the statements made by the manufacturer about the product or service. The Editorial Board has the power to publish accepted articles in the order and date that they consider appropriate, depending on the theme and needs of publication, being possible that articles accepted at a later date are published before others and vice versa


  7. COPYRIGHT ASSIGNMENT: the author should read the declaration of authorship and copyright assignment and should state the existence or not of a conflict of interests in the specific text box.

    Here is the text related to the guarantee and the copyright assignment:

      7.1Author’s guarantees and responsibilities. The author ensures that the texts, including any graphs, designs or illustrations (hereafter generically called “the work”) sent to the Journal of Periodontics, Implantology and Oral Rehabilitation for their publication, are original, unpublished and of their authorship, and that they have not been previously published or simultaneously sent to any other editorial for their publication.

      Equally, the authors ensure, under their responsibility, that they hold all the exploitation rights for the work and that in any case it violates the rights of third parties. And in case that they exploit the rights of third parties, the authors should have obtained the pertinent authorization to exploit them and authorize their exploitation by ScholarOne and the Scientific Journal PIRO. Also, the authors ensure that the work submitted does not fail to complete the regulations of protection of personal data. Specially, they ensure to have obtained the previous authorization and written consent of the patients or their relatives for its publication, when these patients are identified in the work or when the information published makes them easily identifiable

      7.2Assignment of exploitation rights: the author assigns exclusively to the companies with power of assignment to third parties all the exploitation rights coming from the work selected for its publication in this or in any other ScholarOne publication. And in particular, the copyrights, the distribution rights, the rights of public communication (including the interactive assignment) and the transformation (including the adaptation, modification and, if appropriate, the translation), for all the modalities of exploitation (including without limitation : printed format, electronic, on-line, IT or audiovisual support as well as any other format, even with a promotional or advertising purpose and/or for the making of derivative products), worldwide and for all the legal duration of the rights established in the valid consolidated text of Intellectual Property Act. Consequently, the author cannot publish or issue the work selected for its publication in the Journal of Periodontics, Implantology and Oral Rehabilitation, either totally or partially, and cannot authorize its publication to third parties, without the previous express authorization, in writing, by the Journal of Periodontics, Implantology and Oral Rehabilitation. During the sending of the manuscript, the authors will be able to consult the complete text of right assignment conditions athttp://www.revistapiro.cl

Founded in 2008, the scientific Journal of Periodontics, Implantology and Oral Rehabilitation (PIRO) is the official body of scientific expression of the Chilean Society of Periodontology (www.spch.cl), the Chilean Society of Prosthetics and Oral Rehabilitation (www.rehabilitacionoral.cl) and the Chilean Society of Oral Implantology (www.sioch.cl). Beisdes, since 2011 it is the official body of scientific expression of the  Ibero-Panamerican Federation of Periodontics (www.fippdentalearning.org) and since May 2012 of the Ibero-Latin-American Association of Oral Rehabilitation (AILARO).